Myovant Sciences Ltd logo

Myovant Sciences Ltd Share Price (NYSE: MYOV)

▲

-26.98

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 9 Mar 2023

Check the interactive Myovant Sciences Ltd Stock chart to analyse performance

Myovant Sciences Ltd Key Stats

Check Myovant Sciences Ltd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$26.98
Open
$26.99
Market Capitalization
$2.6B
Today's Volume
$2.2M
Revenue TTM
$379.1M
EBITDA
$-145.6M
Earnings Per Share (EPS)
$-1.92
Dividend Yield
0.0%
Profit Margin
-48.47%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Global Institutional Holdings in Myovant Sciences Ltd

  • Name

    Holdings %

  • Bellevue Group AG

    6.08%

  • Wellington Management Company LLP

    5.62%

  • State Street Corporation

    2.99%

  • Goldman Sachs Group Inc

    2.49%

  • Polar Capital Holdings PLC

    2.00%

  • Carlson Capital LP

    1.86%

Analyst Recommendation on Myovant Sciences Ltd Stock

Rating
Trend

Buy

    60%Buy

    40%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Myovant Sciences Ltd(by analysts ranked 0 to 5 stars)

About Myovant Sciences Ltd

Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, which is in Phase II clinical trial for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd.
Organization
Myovant Sciences Ltd
Employees
579
CEO
Mr. David C. Marek
Industry
Health Technology

Important FAQs about investing in MYOV Stock from India :

What is Myovant Sciences Ltd share price today?

Myovant Sciences Ltd share price today is as on at the close of the market. Myovant Sciences Ltd share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Myovant Sciences Ltd share?

Myovant Sciences Ltd share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Myovant Sciences Ltd stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Myovant Sciences Ltd Stock (MYOV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Myovant Sciences Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Myovant Sciences Ltd Shares .

What is the minimum amount required to buy Myovant Sciences Ltd Stock (MYOV) from India?

Indian investors can start investing in Myovant Sciences Ltd (MYOV) shares with as little as ₹89.964 or $1 (as of December 05, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹899.64 in Myovant Sciences Ltd stock (as per the Rupee-Dollar exchange rate as on December 05, 2025). Learn more about fractional shares .

What are the returns that Myovant Sciences Ltd has given to Indian investors in the last 5 years?

Myovant Sciences Ltd stock has given 0.0% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?